{"transactions":[{"id":1570710,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-19T21:23:42.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":51682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents a 10% premium above the closing price of Anika's common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The premium priced stock options vest in three equal annual installments beginning on March 15, 2025."}],"balance_after":51682,"derivative":{"exercise_price":27.98,"expiration_date":"2034-03-11","underlying":"Common Stock","underlying_shares":51682},"source":{"system":"sec-edgar","filing":"0001171843-24-001461","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001461/ownership.xml","form_type":"4"}},{"id":1570709,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-19T21:23:42.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":21329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."}],"balance_after":21329,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":21329},"source":{"system":"sec-edgar","filing":"0001171843-24-001461","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001461/ownership.xml","form_type":"4"}},{"id":1582376,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-13T00:01:28.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":false,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."}],"balance_after":8888,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8888},"source":{"system":"sec-edgar","filing":"0001171843-24-001304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001304/ownership.xml","form_type":"4"}},{"id":1582375,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-13T00:01:28.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":false,"shares":5875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."}],"balance_after":11749,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5875},"source":{"system":"sec-edgar","filing":"0001171843-24-001304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001304/ownership.xml","form_type":"4"}},{"id":1582374,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-13T00:01:28.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":false,"shares":4438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4438},"source":{"system":"sec-edgar","filing":"0001171843-24-001304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001304/ownership.xml","form_type":"4"}},{"id":1582373,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2024-03-13T00:01:28.000Z","date":"2024-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2610,"price":25.79,"value":67311.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Reflects an aggregate of 2,610 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":46955,"source":{"system":"sec-edgar","filing":"0001171843-24-001304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001304/ownership.xml","form_type":"4"}},{"id":1582372,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2024-03-13T00:01:28.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":true,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Reflects the second vesting installment of RSUs granted on March 11, 2022."}],"balance_after":49565,"source":{"system":"sec-edgar","filing":"0001171843-24-001304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001304/ownership.xml","form_type":"4"}},{"id":1582371,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2024-03-13T00:01:28.000Z","date":"2024-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1725,"price":25.42,"value":43849.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Reflects an aggregate of 1,725 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":40677,"source":{"system":"sec-edgar","filing":"0001171843-24-001304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001304/ownership.xml","form_type":"4"}},{"id":1582370,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2024-03-13T00:01:28.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":true,"shares":5875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Reflects the first vesting installment of RSUs granted on March 9, 2023."}],"balance_after":42402,"source":{"system":"sec-edgar","filing":"0001171843-24-001304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001304/ownership.xml","form_type":"4"}},{"id":1582369,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2024-03-13T00:01:28.000Z","date":"2024-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1303,"price":25.42,"value":33122.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 1,303 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":36527,"source":{"system":"sec-edgar","filing":"0001171843-24-001304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001304/ownership.xml","form_type":"4"}},{"id":1582368,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2024-03-13T00:01:28.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":true,"shares":4438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 160 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023."}],"balance_after":37830,"source":{"system":"sec-edgar","filing":"0001171843-24-001304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001304/ownership.xml","form_type":"4"}},{"id":1810285,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2023-08-11T20:30:46.000Z","date":"2023-08-10","kind":"exercise","planned":false,"acquired":false,"shares":3859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3859},"source":{"system":"sec-edgar","filing":"0001171843-23-005271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323005271/ownership.xml","form_type":"4"}},{"id":1810284,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2023-08-11T20:30:46.000Z","date":"2023-08-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1133,"price":18.58,"value":21051.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 1,133 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on August 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on August 10, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":33232,"source":{"system":"sec-edgar","filing":"0001171843-23-005271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323005271/ownership.xml","form_type":"4"}},{"id":1810283,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2023-08-11T20:30:46.000Z","date":"2023-08-10","kind":"exercise","planned":false,"acquired":true,"shares":3859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 668 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 12, 2023."}],"balance_after":34365,"source":{"system":"sec-edgar","filing":"0001171843-23-005271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323005271/ownership.xml","form_type":"4"}},{"id":1955350,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-14T20:47:32.000Z","date":"2023-03-10","kind":"exercise","acquired":false,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."}],"balance_after":17776,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8888},"source":{"system":"sec-edgar","filing":"0001171843-23-001686","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001686/ownership.xml","form_type":"4"}},{"id":1955349,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2023-03-14T20:47:32.000Z","date":"2023-03-10","kind":"tax_withholding","acquired":false,"shares":2609,"price":26.1,"value":68094.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 2,609 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 10, 2023, the trading day immediately preceding the date on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":29838,"source":{"system":"sec-edgar","filing":"0001171843-23-001686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001686/ownership.xml","form_type":"4"}},{"id":1955348,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2023-03-14T20:47:32.000Z","date":"2023-03-10","kind":"exercise","acquired":true,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 11, 2022."}],"balance_after":32447,"source":{"system":"sec-edgar","filing":"0001171843-23-001686","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001686/ownership.xml","form_type":"4"}},{"id":1959625,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-10T21:52:04.000Z","date":"2023-03-09","kind":"exercise","acquired":false,"shares":4439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."}],"balance_after":4438,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4439},"source":{"system":"sec-edgar","filing":"0001171843-23-001597","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001597/ownership.xml","form_type":"4"}},{"id":1959624,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-10T21:52:04.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":38475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents a 10% premium above the closing price of Anika's common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The premium priced stock options vest in three equal annual installments beginning on March 9, 2024."}],"balance_after":38475,"derivative":{"exercise_price":29.6,"expiration_date":"2033-03-09","underlying":"Common Stock","underlying_shares":38475},"source":{"system":"sec-edgar","filing":"0001171843-23-001597","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001597/ownership.xml","form_type":"4"}},{"id":1959623,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-10T21:52:04.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":17624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."}],"balance_after":17624,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":17624},"source":{"system":"sec-edgar","filing":"0001171843-23-001597","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001597/ownership.xml","form_type":"4"}},{"id":1959622,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2023-03-10T21:52:04.000Z","date":"2023-03-09","kind":"tax_withholding","acquired":false,"shares":1303,"price":26.91,"value":35063.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 1,303 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 9, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":23559,"source":{"system":"sec-edgar","filing":"0001171843-23-001597","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001597/ownership.xml","form_type":"4"}},{"id":1959621,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2023-03-10T21:52:04.000Z","date":"2023-03-09","kind":"exercise","acquired":true,"shares":4439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021."}],"balance_after":24862,"source":{"system":"sec-edgar","filing":"0001171843-23-001597","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323001597/ownership.xml","form_type":"4"}},{"id":2188501,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2022-08-11T20:11:49.000Z","date":"2022-08-10","kind":"exercise","acquired":false,"shares":3859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021."}],"balance_after":3859,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3859},"source":{"system":"sec-edgar","filing":"0001171843-22-005617","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322005617/ownership.xml","form_type":"4"}},{"id":2188500,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2022-08-11T20:11:49.000Z","date":"2022-08-10","kind":"exercise","acquired":true,"shares":3859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020. The 3,859 shares resulting from the RSU vest were retained in full as a result of Mr. Levitz's election to pay cash to cover the applicable taxes resulting from the RSU vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 640 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 13, 2022."}],"balance_after":20423,"source":{"system":"sec-edgar","filing":"0001171843-22-005617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322005617/ownership.xml","form_type":"4"}},{"id":2334281,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-15T21:01:01.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":38979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents a 10% premium above the closing price of Anika's common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The premium priced stock options vest in three equal annual installments beginning on March 11, 2023."}],"balance_after":38979,"derivative":{"exercise_price":28.14,"expiration_date":"2032-03-11","underlying":"Common Stock","underlying_shares":38979},"source":{"system":"sec-edgar","filing":"0001171843-22-001905","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001905/ownership.xml","form_type":"4"}},{"id":2334280,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-15T21:01:01.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":26664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."}],"balance_after":26664,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":26664},"source":{"system":"sec-edgar","filing":"0001171843-22-001905","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001905/ownership.xml","form_type":"4"}},{"id":2336376,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2022-03-14T13:00:47.000Z","date":"2022-03-11","kind":"purchase","acquired":true,"shares":4000,"price":24.619,"value":98476.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 11, 2022, Mr. Levitz purchased 4,000 shares in multiple trades ranging from $24.30 to $24.74. The price reported above reflects the weighted average purchase price. Mr. Levitz undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":15924,"source":{"system":"sec-edgar","filing":"0001171843-22-001832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001832/ownership.xml","form_type":"4"}},{"id":2338436,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-11T22:36:58.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":4438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."}],"balance_after":8877,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4438},"source":{"system":"sec-edgar","filing":"0001171843-22-001812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001812/ownership.xml","form_type":"4"}},{"id":2338435,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2022-03-11T22:36:58.000Z","date":"2022-03-09","kind":"exercise","acquired":true,"shares":4438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021. The 4,438 shares resulting from the RSU vest were retained in full as a result of Mr. Levitz's election to pay cash to cover the applicable taxes resulting from the RSU vest."}],"balance_after":11924,"source":{"system":"sec-edgar","filing":"0001171843-22-001812","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001812/ownership.xml","form_type":"4"}},{"id":2604502,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2021-08-13T16:30:26.000Z","date":"2021-08-12","kind":"purchase","acquired":true,"shares":777,"price":40.205,"value":31239.285,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 12, 2021, Mr. Levitz purchased 777 shares in multiple trades ranging from $40.07 to $40.41. The price reported above reflects the weighted average purchase price. Mr. Levitz undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":7486,"source":{"system":"sec-edgar","filing":"0001171843-21-005933","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321005933/ownership.xml","form_type":"4"}},{"id":2604501,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2021-08-13T16:30:26.000Z","date":"2021-08-11","kind":"purchase","acquired":true,"shares":2850,"price":40.206,"value":114587.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 11, 2021, Mr. Levitz purchased 2,850 shares in multiple trades ranging from $39.85 to $40.50. The price reported above reflects the weighted average purchase price. Mr. Levitz undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":6709,"source":{"system":"sec-edgar","filing":"0001171843-21-005933","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321005933/ownership.xml","form_type":"4"}},{"id":2605923,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2021-08-12T20:31:50.000Z","date":"2021-08-10","kind":"exercise","acquired":false,"shares":3859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021."}],"balance_after":7718,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3859},"source":{"system":"sec-edgar","filing":"0001171843-21-005897","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321005897/ownership.xml","form_type":"4"}},{"id":2605922,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Common Stock","published_at":"2021-08-12T20:31:50.000Z","date":"2021-08-10","kind":"exercise","acquired":true,"shares":3859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the first vesting installment of RSUs granted on August 10, 2020. The 3,859 shares resulting from the RSU vest were retained in full as a result of Mr. Levitz's election to pay cash to cover the applicable taxes resulting from the RSU vest."}],"balance_after":3859,"source":{"system":"sec-edgar","filing":"0001171843-21-005897","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321005897/ownership.xml","form_type":"4"}},{"id":2795533,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-11T22:12:08.000Z","date":"2021-03-09","kind":"grant","acquired":true,"shares":33363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents a 10% premium above the closing price of Anika's common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The premium priced stock options vest in three equal annual installments beginning on March 9, 2022."}],"balance_after":33363,"derivative":{"exercise_price":37.4,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":33363},"source":{"system":"sec-edgar","filing":"0001171843-21-001711","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321001711/ownership.xml","form_type":"4"}},{"id":2795532,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2021-03-11T22:12:08.000Z","date":"2021-03-09","kind":"grant","acquired":true,"shares":13315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022."}],"balance_after":13315,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13315},"source":{"system":"sec-edgar","filing":"0001171843-21-001711","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321001711/ownership.xml","form_type":"4"}},{"id":3060869,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-12T20:10:18.000Z","date":"2020-08-10","kind":"grant","acquired":true,"shares":57145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in three equal annual installments beginning August 10, 2021."}],"balance_after":57145,"derivative":{"exercise_price":34.55,"expiration_date":"2030-08-10","underlying":"Common Stock","underlying_shares":57145},"source":{"system":"sec-edgar","filing":"0001171843-20-005857","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320005857/ownership.xml","form_type":"4"}},{"id":3060868,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO, Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2020-08-12T20:10:18.000Z","date":"2020-08-10","kind":"grant","acquired":true,"shares":11577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021."}],"balance_after":11577,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11577},"source":{"system":"sec-edgar","filing":"0001171843-20-005857","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320005857/ownership.xml","form_type":"4"}},{"id":3626637,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2019-03-01T01:44:56.000Z","date":"2019-02-27","kind":"sale","acquired":false,"shares":1350,"price":92.01,"value":124213.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,164 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":56651,"source":{"system":"sec-edgar","filing":"0001127602-19-009058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219009058/form4.xml","form_type":"4"}},{"id":3632594,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2019-02-27T00:08:19.000Z","date":"2019-02-24","kind":"tax_withholding","acquired":false,"shares":2978,"price":87.6,"value":260872.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,164 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":58001,"source":{"system":"sec-edgar","filing":"0001127602-19-008494","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219008494/form4.xml","form_type":"4"}},{"id":3632593,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2019-02-27T00:08:19.000Z","date":"2019-02-22","kind":"tax_withholding","acquired":false,"shares":637,"price":87.6,"value":55801.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,418 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,980 performance share units granted on February 24, 2016, which vest on February 24, 2019; and 2,164 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":60979,"source":{"system":"sec-edgar","filing":"0001127602-19-008494","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219008494/form4.xml","form_type":"4"}},{"id":3650403,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2019-02-19T22:19:48.000Z","date":"2019-02-14","kind":"tax_withholding","acquired":false,"shares":446,"price":84.83,"value":37834.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,418 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; and 4,328 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 2,685 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the following shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan; 263 shares purchased on May 31, 2018 and 67 shares purchased on November 30, 2018."}],"balance_after":61616,"source":{"system":"sec-edgar","filing":"0001127602-19-006921","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219006921/form4.xml","form_type":"4"}},{"id":3942790,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2018-05-08T22:16:27.000Z","date":"2018-05-04","kind":"tax_withholding","acquired":false,"shares":6376,"price":83.88,"value":534818.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,418 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; and 4,328 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 4,027 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":61270,"source":{"system":"sec-edgar","filing":"0001127602-18-016669","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218016669/form4.xml","form_type":"4"}},{"id":4030724,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2018-02-27T23:22:06.000Z","date":"2018-02-24","kind":"tax_withholding","acquired":false,"shares":1007,"price":75.55,"value":76078.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,343 restricted stock units granted on May 4, 2015, which vest on May 4, 2018; 3,418 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; and 4,328 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 4,027 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 462 shares acquired on November 30, 2017 under the Insulet Corporation 2007 Employee Stock Purchase Plan."}],"balance_after":67646,"source":{"system":"sec-edgar","filing":"0001127602-18-008810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218008810/form4.xml","form_type":"4"}},{"id":4030723,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2018-02-27T23:22:06.000Z","date":"2018-02-24","kind":"tax_withholding","acquired":false,"shares":1762,"price":75.55,"value":133119.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,343 restricted stock units granted on May 4, 2015, which vest on May 4, 2018; 3,418 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; and 4,328 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 4,027 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 462 shares acquired on November 30, 2017 under the Insulet Corporation 2007 Employee Stock Purchase Plan."}],"balance_after":68653,"source":{"system":"sec-edgar","filing":"0001127602-18-008810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218008810/form4.xml","form_type":"4"}},{"id":4034345,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2018-02-27T01:07:15.000Z","date":"2018-02-22","kind":"tax_withholding","acquired":false,"shares":677,"price":80.46,"value":54471.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,343 restricted stock units granted on May 4, 2015, which vest on May 4, 2018; 6,836 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019; 11,962 performance share units granted on February 24, 2016, which vest as to one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019; and 4,328 restricted stock units granted on February 22, 2017, which vest one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; and 4,027 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 462 shares acquired on November 30, 2017 under the Insulet Corporation 2007 Employee Stock Purchase Plan."}],"balance_after":70415,"source":{"system":"sec-edgar","filing":"0001127602-18-008531","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218008531/form4.xml","form_type":"4"}},{"id":4055304,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-16T01:08:34.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":10492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":10492,"derivative":{"exercise_price":74.5,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":10492},"source":{"system":"sec-edgar","filing":"0001127602-18-006482","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218006482/form4.xml","form_type":"4"}},{"id":4055303,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2018-02-16T01:08:34.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":4027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The 4,027 restricted stock units vest one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,343 restricted stock units granted on May 4, 2015, which vest on May 4, 2018; 6,836 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019; and 6,491 restricted stock units granted on February 22, 2017, which vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 462 shares acquired on November 30, 2017 under the Insulet Corporation 2007 Employee Stock Purchase Plan."}],"balance_after":71092,"source":{"system":"sec-edgar","filing":"0001127602-18-006482","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218006482/form4.xml","form_type":"4"}},{"id":4055302,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2018-02-16T01:08:34.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":11962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 11,962 performance share units were granted on February 24, 2016, and the Compensation Committee of the Board of Directors determined on February 13, 2018 that the performance share units were earned based on the performance of the Company.  The full award remains subject to time-based vesting in accordance with the following schedule: one-half of the performance share units vest on the second anniversary of the date of grant and one-half of the performance share units vest on the third anniversary of the date of grant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,343 restricted stock units granted on May 4, 2015, which vest on May 4, 2018; 6,836 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019; and 6,491 restricted stock units granted on February 22, 2017, which vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 462 shares acquired on November 30, 2017 under the Insulet Corporation 2007 Employee Stock Purchase Plan."}],"balance_after":67065,"source":{"system":"sec-edgar","filing":"0001127602-18-006482","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218006482/form4.xml","form_type":"4"}},{"id":4424969,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-02-24T23:39:59.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":17058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment."}],"balance_after":17058,"derivative":{"exercise_price":46.22,"expiration_date":"2027-02-22","underlying":"Common Stock","underlying_shares":17058},"source":{"system":"sec-edgar","filing":"0001127602-17-008314","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760217008314/form4.xml","form_type":"4"}},{"id":4424968,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":92917,"kind":"person","name":"Levitz Michael L","position":1,"cik":"0001468019","reported_name":"Levitz Michael L","relationship":{"officer":true,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2017-02-24T23:39:59.000Z","date":"2017-02-22","kind":"grant","acquired":true,"shares":6491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 6,491 restricted stock units vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 28,686 restricted stock units granted on May 4, 2015, which vest one-half of the total units on May 4, 2017 and one-half of the total units on May 4, 2018; and 6,836 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019, subject to continued employment.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":55103,"source":{"system":"sec-edgar","filing":"0001127602-17-008314","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760217008314/form4.xml","form_type":"4"}}]}